These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 9548811)

  • 1. 4-Amino-2-[4-[1-(benzyloxycarbonyl)-2(S)- [[(1,1-dimethylethyl)amino]carbonyl]-piperazinyl]-6, 7-dimethoxyquinazoline (L-765,314): a potent and selective alpha1b adrenergic receptor antagonist.
    Patane MA; Scott AL; Broten TP; Chang RS; Ransom RW; DiSalvo J; Forray C; Bock MG
    J Med Chem; 1998 Apr; 41(8):1205-8. PubMed ID: 9548811
    [No Abstract]   [Full Text] [Related]  

  • 2. Design, synthesis, and biological activity of prazosin-related antagonists. Role of the piperazine and furan units of prazosin on the selectivity for alpha1-adrenoreceptor subtypes.
    Bolognesi ML; Budriesi R; Chiarini A; Poggesi E; Leonardi A; Melchiorre C
    J Med Chem; 1998 Nov; 41(24):4844-53. PubMed ID: 9822553
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The cyano-NNO-azoxy function in the design of an irreversible label for alpha 1 adrenoreceptors.
    Sorba G; Di Stilo A; Medana C; Cena C; Gasco A; Orsetti M
    Bioorg Med Chem; 1995 Feb; 3(2):173-8. PubMed ID: 7796051
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Studies on quinazolines and 1,2,4-benzothiadiazine 1,1-dioxides. 8.1, 2 synthesis and pharmacological evaluation of tricyclic fused quinazolines and 1,2,4-benzothiadiazine 1,1-dioxides as potential alpha1-adrenoceptor antagonists.
    Chern JW; Tao PL; Wang KC; Gutcait A; Liu SW; Yen MH; Chien SL; Rong JK
    J Med Chem; 1998 Aug; 41(17):3128-41. PubMed ID: 9703460
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Design, synthesis, and biological evaluation of prazosin-related derivatives as multipotent compounds.
    Antonello A; Hrelia P; Leonardi A; Marucci G; Rosini M; Tarozzi A; Tumiatti V; Melchiorre C
    J Med Chem; 2005 Jan; 48(1):28-31. PubMed ID: 15633998
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Design and synthesis of novel alpha1a adrenoceptor-selective dihydropyridine antagonists for the treatment of benign prostatic hyperplasia.
    Nagarathnam D; Wetzel JM; Miao SW; Marzabadi MR; Chiu G; Wong WC; Hong X; Fang J; Forray C; Branchek TA; Heydorn WE; Chang RS; Broten T; Schorn TW; Gluchowski C
    J Med Chem; 1998 Dec; 41(26):5320-33. PubMed ID: 9857099
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and alpha(1)-adrenoceptor antagonist activity of derivatives and isosters of the furan portion of (+)-cyclazosin.
    Sagratini G; Angeli P; Buccioni M; Gulini U; Marucci G; Melchiorre C; Leonardi A; Poggesi E; Giardinà D
    Bioorg Med Chem; 2007 Mar; 15(6):2334-45. PubMed ID: 17276073
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacological evaluation of prazosin- and doxazosin-related compounds with modified piperazine ring.
    Giardinà D; Crucianelli M; Marucci G; Melchiorre C; Polidori C; Pompei P; Massi M
    Arzneimittelforschung; 1996 Nov; 46(11):1054-9. PubMed ID: 8955864
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacology of terazosin: an alpha 1-selective blocker.
    Kyncl JJ
    J Clin Pharmacol; 1993 Sep; 33(9):878-83. PubMed ID: 7901242
    [No Abstract]   [Full Text] [Related]  

  • 10. Analogues of prazosin that bear a benextramine-related polyamine backbone exhibit different antagonism toward alpha1-adrenoreceptor subtypes.
    Bolognesi ML; Marucci G; Angeli P; Buccioni M; Minarini A; Rosini M; Tumiatti V; Melchiorre C
    J Med Chem; 2001 Feb; 44(3):362-71. PubMed ID: 11462977
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Design and synthesis of selective alpha1B adrenoceptor antagonists.
    Hayashi R; Ohmori E; Isogaya M; Moriwaki M; Kumagai H
    Bioorg Med Chem Lett; 2006 Aug; 16(15):4045-7. PubMed ID: 16723224
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prazosin-related compounds. Effect of transforming the piperazinylquinazoline moiety into an aminomethyltetrahydroacridine system on the affinity for alpha1-adrenoreceptors.
    Rosini M; Antonello A; Cavalli A; Bolognesi ML; Minarini A; Marucci G; Poggesi E; Leonardi A; Melchiorre C
    J Med Chem; 2003 Nov; 46(23):4895-903. PubMed ID: 14584940
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recent advances in selective alpha1-adrenoreceptor antagonists as antihypertensive agents.
    Jain KS; Bariwal JB; Kathiravan MK; Phoujdar MS; Sahne RS; Chauhan BS; Shah AK; Yadav MR
    Bioorg Med Chem; 2008 May; 16(9):4759-800. PubMed ID: 18378462
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Binding of [(3)H]prazosin to alpha(1A)- and alpha(1B)-adrenoceptors, and to a cimetidine-sensitive non-alpha(1) binding site in rat kidney membranes.
    Mugisha P; Gründemann D; Schömig E; Uhlén S
    Naunyn Schmiedebergs Arch Pharmacol; 2002 May; 365(5):335-40. PubMed ID: 12012018
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structure-activity relationships in 1,4-benzodioxan-related compounds. 6. Role of the dioxane unit on selectivity for alpha(1)-adrenoreceptor subtypes.
    Quaglia W; Pigini M; Piergentili A; Giannella M; Marucci G; Poggesi E; Leonardi A; Melchiorre C
    J Med Chem; 1999 Jul; 42(15):2961-8. PubMed ID: 10425105
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antipsychotics lack alpha 1A/B adrenoceptor subtype selectivity in the rat.
    Cahir M; King DJ
    Eur Neuropsychopharmacol; 2005 Mar; 15(2):231-4. PubMed ID: 15695070
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Involvement of central alpha1- and alpha2-adrenoceptors on cardiovascular responses to moxonidine.
    Moreira TS; Takakura AC; Menani JV; Colombari E
    Eur J Pharmacol; 2007 Jun; 563(1-3):164-71. PubMed ID: 17382316
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of intracavernous administration of selective antagonists of alpha(1)-adrenoceptor subtypes on erection in anesthetized rats and dogs.
    Sironi G; Colombo D; Poggesi E; Leonardi A; Testa R; Rampin O; Bernabé J; Giuliano F
    J Pharmacol Exp Ther; 2000 Mar; 292(3):974-81. PubMed ID: 10688612
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis, pharmacological evaluation, and structure-activity relationship and quantitative structure-activity relationship studies on novel derivatives of 2,4-diamino-6,7-dimethoxyquinazoline alpha1-adrenoceptor antagonists.
    Leonardi A; Motta G; Boi C; Testa R; Poggesi E; De Benedetti PG; Menziani MC
    J Med Chem; 1999 Feb; 42(3):427-37. PubMed ID: 9986714
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and biological activities of 2-[(heteroaryl)methyl]imidazolines.
    Saczewski J; Hudson A; Scheinin M; Rybczynska A; Ma D; Saczewski F; Laird S; Laurila JM; Boblewski K; Lehmann A; Gu J; Watts H
    Bioorg Med Chem; 2012 Jan; 20(1):108-16. PubMed ID: 22172308
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.